Australian Green Party Proposes Cannabis Legalization

The Australian Parliamentary Budget Office has found that legalizing cannabis throughout the nation would be worth nearly $2 billion a year for the government, according to a Guardian report. The Green Party has proposed a plan to tax-and-regulate cannabis for adults, which, according to the PBO, would raise $3.6 billion over the first four years […]

Read More - -

Tags: , ,

Australian Company Set to Begin MMJ for Dogs Study

Australia’s CannPal Animal Therapeutics has received medical cannabis oils from Canada’s Aphria Inc to begin clinical trials of what it calls its lead drug candidate, known as CPAT-01. The company has already completed the dog selection for the live phase of the study, which will be conducted in two phases. The first phase will involve 11 […]

Read More - -

Tags: , , ,

New South Wales, Australia Streamlines MMJ Process for Patients

New South Wales Health Minister Greg Hunt has “taken a machete” to the federal medical cannabis regulations in order to allow “direct and immediate access” to the program for patients, the Australian Broadcasting Company reports. The changes will take effect in the coming weeks. “Where the doctors say it is required, we’ll make sure it […]

Read More - -

Tags: ,

Australia Gives Green Light for MMJ Exports

Australia’s health minister has announced medical cannabis producers in the nation will be able to export products to other countries with federal cannabis programs, according to an Australian Associated Press report. “By helping the domestic manufacturers to expand, this, in turn, helps to ensure an ongoing supply of medicinal cannabis products here in Australia.” – […]

Read More - -

Tags:

Australian Government Releases MMJ Guidelines

The Australian government has released guidelines for physicians to effectively use cannabis as a treatment for chronic pain and epilepsy. Included is advice about whether patients with chemotherapy-induced nausea and vomiting and terminally ill patients in palliative care could benefit from medical cannabis treatments, according to a Courier Mail outline of the directive. The guidelines also […]

Read More - -

Tags:

Children’s Hospital of Philadelphia Partners with Australian Biopharmaceutical Firm on Autism Study

The Children’s Hospital of Philadelphia is partnering with Australian biopharmaceutical firm Zelda Therapeutics on an observational study into the effects of medical cannabis on autistic children, according to a Philadelphia Inquirer report. The study participants will already be covered under the Pennsylvania medical cannabis Safe Harbor provision. “This is truly an observational study. We’re not […]

Read More - -

Tags: , , ,

Australian MMJ and Hemp Firm Expands into China

Australia’s Creso Pharma is expanding its reach into China, announcing the company has established a strategic partnership and commercial distribution agreement with hemp-producer Zhejiang Kingdom Create So., Ltd. Kingdom Creative will import hemp and cannabis-derived animal and human health products and invest in the marketing and distribution of the products. Dr. Miri Halperin Wernli, Creso […]

Read More - -

Tags: ,

Canadian Companies Partner for Australia’s Largest MMJ Greenhouse

Two Canadian businesses are partnering to build a 1 million-square-foot greenhouse in Casino, New South Wales, Australia for medical cannabis cultivation, according to a report from the Construction Index. The PUF Ventures and MYM Nutraceuticals project will be completed in two stages; the first phase will cover about 300,000 square feet – which alone would […]

Read More - -

Tags: ,

Australian University Nets Multi-Million-Dollar Grant for Cannabinoid Research

The University of Newcastle, in Callaghan, New South Wales, Australia, has received a $2.5 million (USD$1.95 million) grant from the National Health and Medical Research Council to set up the Australian Centre for Cannabinoid Clinical and Research Excellence, the Illawarra Mercury reports. The funds are part of a larger $6 million ($4.7 million) grant to […]

Read More - -

Tags: ,

Zelda Therapeutics-led Observational Study Finds Hope for MMJ as Autism Therapy

In an observational study by Australia’s Zelda Therapeutics Ltd., 21 autism patients demonstrated significant symptom improvements when treated with medical cannabis extracts over a 12-week period. The study found that 71.4 percent of patients treated with the extracts instead of traditional medications, such as atypical antipsychotics, showed improvement in at least one core symptom, including […]

Read More - -

Tags: , ,

Queensland, Australia Advances Plan to Allow Hemp Products for Human Consumption

The Queensland, Australia government has introduced legislation to amend the Drugs Misuse Act of 1986 to allow the cultivation of hemp seeds for human consumption. Agriculture and Fisheries Minister Bill Byrne said the reforms “would provide investment and trade opportunities for Queensland producers.” “By allowing industrial cannabis seed to be grown for human consumption, there […]

Read More - -

Tags: ,

Australian MMJ Program Requirements too ‘Onerous’ for Many Would-be Patients

Australian patients and physicians are lamenting the lack-of-access to medical cannabis in the nation, claiming that the strict regulations are forcing seriously ill patients into the illicit market, the Australian Broadcasting Company reports. “It just seems that so many obstacles are being put in place of [general practitioners] and specialists that it’s creating an impossible […]

Read More - -

Tags:

Australian MMJ Company Agrees to Purchase Canadian MMJ Applicant

Australian medical cannabis company Creso Pharma has agreed to acquire Canadian cannabis company Mernova Medicinal, who has applied to become the first licensed producer in Nova Scotia, for more than $8.1 million (A$10.2 million, C$10.18). Under current Canadian law, companies must prove they can cultivate cannabis crops before receiving a state license. Creso and Mernova […]

Read More - -

Tags: ,

Australia Approves MMJ Research Licenses to Two Firms

Australia’s Office of Drug Control has issued medical cannabis research licenses to two firms allowing them to cultivate and manufacture products for medical studies. The licenses were awarded to Canndeo LTD., a wholly-owned subsidiary of The Hydroponics Company (THC); and to a partnership between AusCann and Tasmanian Alkaloids. According to a report from the Examiner, […]

Read More - -

Tags: ,

Australian Firm Set to Trial Two Cannabis-Derived Drugs

Australia’s Medlab Clinical Limited is expected to begin trials of two cannabis-derived medicines after receiving approval from the Human Research Ethics Committee, according to an Australian Journal of Pharmacy report. Both drugs are being considered as cancer therapies. NanaBis will be tested in advanced stage cancer patients with intractable pain. The product, which contains both […]

Read More - -

Tags: ,

Australia’s ‘Dr. Pot’ Arrested, Charged with Drug Crimes

An Australian physician who has experimented with the medical uses of cannabis since 1990 has been arrested and charged with drug possession, according to a Daily Telegraph report. Dr. Andrew Katelaris, 62, was arrested in his home where police seized cannabis and cash they claim is proceeds from crime. Katelaris was deregistered as a physician […]

Read More - -

Tags: ,

Australia’s Revised MMJ Rules Not Improving Access

Despite a ruling by Australia’s Therapeutic Goods Administration to make medical cannabis more available for patients, some lawmakers are arguing that the scheme has actually made access more difficult, the Australian Broadcasting Company reports. Under the original plan, first approved in 1992, a limited number of patients were allowed access to medical cannabis, under what […]

Read More - -

Tags: ,

Australian MMJ Skin Care Line Expected Throughout Europe This Year

Australia’s MGC Pharmaceuticals has completed the final clinical trials of their cannabis skin care line with 92 percent of participants saying they would continue using the creams they tested, Business News Western Australia reports. The products were independently tested on 90 volunteers over a three-month period by Dr. Rok Devjak at a dermatology clinic in […]

Read More - -

Tags: ,

Australia and New Zealand Approve Hemp Food Sales

The Australian and New Zealand Ministerial Forum on Food Regulation has approved the sale of hemp as food but also imposed strict guidelines around the products’ marketing and labeling, according to Grain Central, an Australian grain industry publication. The guidelines ban any references to the presence of CBD in the product and prevent any branding […]

Read More - -

Tags:

AusCann Granted MMJ Cultivation License for Western Australia

Australia’s Office of Drug Control has granted a medical cannabis cultivation license to AusCann – believed to be the first license issued in Western Australia, Perth Now reports. The company, led by former federal Liberal Member of Parliament Mal Washer, will partner with Canada’s Canopy Growth Corporation to import medical cannabis from Chile until their […]

Read More - -

Tags: , ,

Australia Receives First MMJ Imports from Canada

The first medical cannabis products to be imported into Australia under the recently enacted federal guidelines have arrived in Melbourne and Perth, which means approved patients no longer have to wait for their medicine to be imported, the Australian Broadcasting Company reports. Until now, medical cannabis was only imported into the country on a case-by-case […]

Read More - -

Tags: ,

Australian Tea Tree Farm Developing Canna-Honey Nets $1.49M Investment

Jenbrook, an organic tea tree farm in New South Wales, Australia has received a $1.49 million investment to help develop honey products from bees that have pollinated cannabis plants, Business Insider Australia reports. Jenbrook supplies raw honey and tea tree oil to the U.S. through Naturally Australian Products. The company, which is expected to reach […]

Read More - -

Tags:

Medifarm Granted First MMJ License in Queensland, Australia

Medifarm, a Queensland, Australia-based company, is the first to be issued a license to legally cultivate and produce medical cannabis in the state, the Brisbane Times reports. The company plans to supply 5,000 customers by early 2018. Adam Benjamin, director of Medifarm, said they will be using products imported from Israel as a “stopgap measure […]

Read More - -

Tags:

AusCann and DayaCann Harvest Their First Crop in Chile

Australia-based AusCann Holdings is harvesting its first crop in Chile as part of a 50-50 partnership with Fundacion Daya. The estimated 660-plus pound crop, planted by DayaCann, will be sent to a manufacturing facility for processing into medical cannabis formulations. “We’re delighted with the harvest of our first crop with our partner Fundacion Daya and […]

Read More - -

Tags: ,

You are viewing cannabis news and information related to Australia. View all cannabis news >>